Correction: ‘How valid is a prescription-based multimorbidity index (Rx-risk) in predicting mortality in the Outcomes and Multimorbidity In Type 2 diabetes (OMIT) study? A nation-wide registrybased cohort study from Norway’

Unknown · 2024

Read Correction: ‘How valid is a prescription-based multimorbidity index (Rx-risk) in predicting mortality in the Outcomes and Multimorbidity In Type 2 diabetes (OMIT) study? A nation-wide registrybased cohort study from Norway’ by Unknown (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11624793.txt.

Description

2024;14:e077027. doi:10.1136/ bmjopen-2023-077027 This article has been corrected since it was published online. The estimated weights in the last column of Table 2 were missing for most of the morbidities and erroneous for others. In addition, some of the morbidities labelled with footnotes had been labelled with the wrong footnote symbol.

Catalog record

CREATORUnknown
YEAR2024
COLLECTIONPAPERS
FORMATTXT
FILE SIZE5 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC11624793

Browse the full library · About the Tower of Babel